EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation

Ji-Huan Wang iD, Hong-Biao Sheng, Jun-Kun Li

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Ji-Huan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Fengcheng Hospital of Fengxian District, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Relaxin, Microglia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to assess the therapeutic effectiveness of Relaxin‐2 (RLN‐2) in promoting functional recovery and neuroprotection following spinal cord injury (SCI) in mice. Furthermore, continuous subcutaneous infusion of Serelaxin (0.5 mg/kg/day; human recombinant relaxin‐2) improved neurological recovery, as evidenced by higher Basso‐Beattie‐Bresnahan (BBB) scores and reduced foot‐stepping angles compared to the SCI group. Additionally, RLN‐2 effectively reduced edema in the injured spinal cord, as shown by decreased water content and downregulated AQP4 expression at mRNA and protein levels. RLN‐2 reduced oxidative stress markers such as malondialdehyde (MDA) and reactive oxygen species (ROS) and increased the activity of catalase (CAT). Further, RLN‐2 mitigated neuroinflammation by reducing the levels of pro‐inflammatory cytokines (TNF‐α and IL‐6) and by inhibiting the activation of M1 microglia while promoting the polarization of M2 microglia. It also inhibited the activation of the NF‐κB signaling and strengthened the activation of the STAT6 signaling in the spinal cord of SCI mice. These findings suggest that RLN‐2 may be a promising therapeutic agent for the treatment of spinal cord injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesRelaxinMicrogliaAnimalsMiceAquaporin 4Oxidative StressNF-kappa BHumansSignal TransductionReactive Oxygen SpeciesTumor Necrosis Factor-alphaSpinal CordInterleukin-6Recombinant ProteinsMice, Inbred C57BLMalondialdehydeMaleCatalaseNeuroprotective Agents

Stichwörter der Autor:innen

AQP4BBBM2 microglia activationRelaxin‐2spinal cord injury (SCI)

Substanzen

RelaxinAquaporin 4NF-kappa BRLN2 protein, humanReactive Oxygen SpeciesTumor Necrosis Factor-alphaInterleukin-6Recombinant ProteinsMalondialdehydeCatalase

Autor:innen und Institutionen

  • Department of Orthopedics, Fengcheng Hospital of Fengxian District, Shanghai, People's Republic of China.

ORCID-Profile: Ji-Huan Wang

Zitieren

APA

Wang, J. H., Sheng, H. B., & Li, J. K. (2025). Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70041

Vancouver

Wang JH, Sheng HB, Li JK. Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70041

BibTeX
@article{Wang2025,
  author = {Wang, Ji-Huan and Sheng, Hong-Biao and Li, Jun-Kun},
  title = {Relaxin‐2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70041}
}
Kostenlos starten →